Vicarious Surgical (RBOT) Return on Capital Employed (2021 - 2025)
Vicarious Surgical's (RBOT) quarterly Return on Capital Employed came in at 174.52% in Q3 2025, down 8889.0% year-on-year from 1.99% in Q3 2024, and down 20.68% on a QoQ basis from 144.61% in Q2 2025.
Vicarious Surgical (RBOT) Return on Capital Employed (2021 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 5 years of Return on Capital Employed data on file, last reported at 174.52% in Q3 2025.
- On a quarterly basis, Return on Capital Employed fell 8889.0% year-over-year to 174.52% in Q3 2025; TTM through Sep 2025 was 174.52%, a 8889.0% decrease from a year earlier, with the FY2024 full-year figure at 77.28%, down 1159.0% from the prior year.
- Return on Capital Employed for Q3 2025 stood at 174.52%, down from 144.61% in the prior quarter.
- Over the last five years, Return on Capital Employed for RBOT reached as high as 5.52% in Q2 2021 and fell as low as 174.52% in Q3 2025.
- Historically, Return on Capital Employed has averaged 68.0% across 5 years, with a median of 67.97% in 2023.
- Across the five-year window, Return on Capital Employed soared 542 bps in 2024 and plunged 8889 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 21.09% in 2021, then slumped by 177 bps to 58.41% in 2022, then fell by 16 bps to 67.97% in 2023, then plunged by 47 bps to 100.08% in 2024, then sank by 74 bps to 174.52% in 2025.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 174.52% in Q3 2025, 144.61% in Q2 2025, and 123.65% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -174.52% |
| Jun 30, 2025 | -144.61% |
| Mar 31, 2025 | -123.65% |
| Dec 31, 2024 | -100.08% |
| Sep 30, 2024 | -85.63% |
| Jun 30, 2024 | -76.75% |
| Mar 31, 2024 | -69.27% |
| Dec 31, 2023 | -67.97% |
| Sep 30, 2023 | -77.60% |
| Jun 30, 2023 | -82.17% |
| Mar 31, 2023 | -67.90% |
| Dec 31, 2022 | -58.41% |
| Sep 30, 2022 | -53.05% |
| Jun 30, 2022 | -38.57% |
| Mar 31, 2022 | -29.34% |
| Dec 31, 2021 | -21.09% |
| Sep 30, 2021 | -9.08% |
| Jun 30, 2021 | -5.52% |
| Mar 31, 2021 | -6.86% |